- Home
- HLVX vs DOMH Comparison
HLVX vs DOMH Comparison
Compare HLVX & DOMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLVX
- DOMH
- Stock Information
- Founded
- HLVX 2020
- DOMH 1967
- Country
- HLVX United States
- DOMH United States
- Employees
- HLVX N/A
- DOMH N/A
- Industry
- HLVX Biotechnology: Pharmaceutical Preparations
- DOMH Biotechnology: Pharmaceutical Preparations
- Sector
- HLVX Health Care
- DOMH Health Care
- Exchange
- HLVX Nasdaq
- DOMH Nasdaq
- Market Cap
- HLVX 83.7M
- DOMH 83.3M
- IPO Year
- HLVX 2022
- DOMH N/A
- Fundamental
- Price
- HLVX $1.97
- DOMH $5.44
- Analyst Decision
- HLVX Hold
- DOMH
- Analyst Count
- HLVX 5
- DOMH 0
- Target Price
- HLVX $2.33
- DOMH N/A
- AVG Volume (30 Days)
- HLVX 436.7K
- DOMH 312.8K
- Earning Date
- HLVX 08-07-2025
- DOMH 08-07-2025
- Dividend Yield
- HLVX N/A
- DOMH 5.84%
- EPS Growth
- HLVX N/A
- DOMH N/A
- EPS
- HLVX N/A
- DOMH N/A
- Revenue
- HLVX N/A
- DOMH $24,891,000.00
- Revenue This Year
- HLVX N/A
- DOMH N/A
- Revenue Next Year
- HLVX N/A
- DOMH N/A
- P/E Ratio
- HLVX N/A
- DOMH N/A
- Revenue Growth
- HLVX N/A
- DOMH 630.80
- 52 Week Low
- HLVX $1.34
- DOMH $0.83
- 52 Week High
- HLVX $15.25
- DOMH $13.58
- Technical
- Relative Strength Index (RSI)
- HLVX 58.49
- DOMH 51.73
- Support Level
- HLVX $1.83
- DOMH $5.47
- Resistance Level
- HLVX $1.95
- DOMH $6.08
- Average True Range (ATR)
- HLVX 0.08
- DOMH 0.55
- MACD
- HLVX 0.00
- DOMH 0.02
- Stochastic Oscillator
- HLVX 60.78
- DOMH 35.76
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.
About DOMH Dominari Holdings Inc.
Dominari Holdings Inc through its various subsidiaries, is currently engaged in wealth management, investment banking, securities sales and trading and asset management. The company operates in two reportable business segments: Dominari Financial and Legacy AIkido. The Dominari Financial reportable business segment represents the Company's broker-dealer business, which is composed of mostly underwriting and transactional service activities. The Legacy AIkido reportable business segment includes Aikido Labs, which manages the investments holdings of the legacy entity. It generates the majority of its revenue from the Dominari Financial segment.